Related Experiment Video
Updated: Oct 26, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Nivolumab-Induced Granuloma Annulare
Bilal Fawaz1, Analisa Halpern1
1Division of Dermatology, Cooper Medical School, Rowan University, Camden, New Jersey.
Abstract:
Immune-checkpoint inhibitors (ICIs) such as pembrolizumab and nivolumab have transformed oncologic therapeutic modalities. By disrupting tumor-induced immunosuppression, ICIs have facilitated effective treatment of numerous malignancies, including metastatic melanoma; however, due to the ensuing disturbance of the immune system, various immune-mediated adverse reactions have been reported with ICI therapy. We present a case of nivolumab-induced granuloma annulare in a 54-year-old woman. Recognition of the association between ICI therapy and cutaneous adverse reactions is crucial to ensure accurate diagnosis and adequate treatment of such reactions in patients taking ICIs.
Related Concept Videos
Tumor Immunotherapy
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Abnormal Proliferation
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

